About Novo Nordisk

We are committed to patients, communities, and the environment. Novo Nordisk is a focused health care company and a world leader in diabetes care.

The well-being of people with chronic illness has always been at the heart of our company. Our roots reach back to 1923 when a man was driven to find a diabetes treatment for his wife. We carry that same passion and commitment beyond diabetes into our work for people with growth hormone-related disorders.

The Triple Bottom Line

Novo Nordisk is committed to doing business in a responsible manner. We adopted our "Triple Bottom Line" approach more than a decade ago, and the principle is now anchored in the company’s values.
In all work, we strive to be:

  • Economically viable

    Economically viable

  • Socially responsible

    Socially responsible

  • Environmentally sound

    Environmentally sound

The Triple Bottom Line ensures that we remain balanced. At Novo Nordisk, it’s not just about making a profit; it’s also about how profits are earned and how we conduct ourselves as a company. From an environmental standpoint, our consciousness is not just a token effort. We believe that by conducting our business in an environmentally sustainable way, we will promote positive change.

Social Responsibility

Novo Nordisk has been recognized for its commitment to the values and ethics that are embodied by its Triple Bottom Line.
Following are just a few of the awards we’ve received:

  • Ranked #5 in the Top 100 sustainable companies at the Annual Summit of Green Companies held in Kunming, China, 2013.
  • Global 100 Most Sustainable Corporations in the World Index by Corporate Knights:
    • In 2013, ranked highest in the Pharmaceuticals and Biotechnology industry group and # 5 overall
    • In 2012, ranked #1 in the world
    • Named on the list from 2005 – 2011 (every year the list has been published).
  • Platinum Corporate Philanthropy Award given by the American College of Endocrinology, 2011
  • Given a 92% environmental score in the 2011 Dow Jones Sustainability Index
  • Corporate Leadership Award from the National Hemophilia Foundation, 2011
  • Awarded Gold Class distinction by Sustainability Asset Management in the Sustainability Yearbook 2011
  • Named one of the World’s Most Ethical Companies by Ethisphere Magazine, 2010

Green Power

In 2006, Novo Nordisk became a member of the World Wide Fund for Nature (WWF) Climate Savers program. By increasing efficiency, Climate Savers companies are decreasing CO2 emissions while growing the company. We’re one of only two pharmaceutical companies officially registered as a Climate Saver.

We set an ambitious target for our CO2 emissions from production: To achieve an absolute reduction of 10% by 2014 compared with 2004 emission levels.
To meet this goal, we:

  • Converted all of our Danish operations to 100% wind power in 2010.
  • Reduced our CO2 emissions from energy consumption by 56%, 2011 compared with 2004
  • We beat our 2014 goal 5 years ahead of schedule.
  • Novo Nordisk saves energy at Danish production facilities.

  • The financial savings are earmarked to purchase green electricity.

  • The energy is supplied from a new wind farm in the North Sea.

  • Danish production sites are powered by green electricity.